Phase 2 trial of recombinant tumor necrosis factor-alpha in combination with dactinomycin in children with recurrent Wilms tumor

Document Type

Journal Article

Publication Date

2008

Journal

Journal of Immunotherapy

Volume

31

Issue

7

Inclusive Pages

679-683

This document is currently not available here.

Share

COinS